Cargando…
Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis
Dyspnea is a prevalent symptom that significantly reduces quality of life of cancer patients. Palliative treatment is necessary when the symptoms do not respond to treatment for their cause. Opioids are widely used as pharmacological therapy, but evidence for individual agents is inconsistent. The p...
Autores principales: | Takagi, Yusuke, Sato, Junya, Yamamoto, Yoshihiro, Matsunuma, Ryo, Watanabe, Hiroaki, Mori, Masanori, Hasegawa, Takaaki, Matsuda, Yoshinobu, Kako, Jun, Kasahara, Yoko, Goya, Sho, Kohara, Hiroyuki, Nakayama, Takeo, Yamaguchi, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390357/ https://www.ncbi.nlm.nih.gov/pubmed/37338727 http://dx.doi.org/10.1007/s10147-023-02362-6 |
Ejemplares similares
-
Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer
por: Yasuda, Shuntaro, et al.
Publicado: (2023) -
Research policy in supportive care and palliative care for cancer dyspnea
por: Matsuda, Yoshinobu, et al.
Publicado: (2021) -
Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians
por: Matsuda, Yoshinobu, et al.
Publicado: (2020) -
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
por: Mori, Masanori, et al.
Publicado: (2022) -
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer
por: Mori, Masanori, et al.
Publicado: (2020)